Role of intestinal microbiocenosis in pathogenesis of acute myocardial infarction
https://doi.org/10.33667/2078-5631-2022-30-34-36
Abstract
Objective. To study changes in the qualitative and quantitative composition of the microbiome of the gastrointestinal tract as one of the main factors affecting the state of general and local immunity in patients with acute myocardial infarction.
Methods. According to the recommendations of the European Society of Cardiology 2019, the cardiological status of the subjects was established. Based on the methodology proposed by the Moscow Research Institute of Epidemiology and Microbiology n. a. G. N. Gabrichevsky, the qualitative and quantitative composition of the intestinal microbiota was determined, followed by an assessment of the degree of microbiological disorders according to the industry standard ‘Protocol of patient management. Intestinal dysbiosis’.
Results and conclusions. A bacteriological study revealed a reduction in the main representatives of the normobiota: Bifidobacterium, Eubacterium, Lactobacterium, Enterococcus spp., forming the ‘metabolic core’ of intestinal microbiocenosis. The results obtained are part of a clinical and laboratory study of changes in the microbiota of the body in diseases of the circulatory system and can serve as a basis for developing recommendations for effective treatment and prevention of cardiovascular pathology, taking into account the state of intestinal microbiocenosis.
About the Authors
A. Yu. Bukaevskaya
Volgograd Regional Clinical Cardiology Centre
Russian Federation
Russian Federation
Bukaevskaya Aleksandra Yu., doctor of clinical laboratory diagnostics1
Volgograd
A. T. Yakovlev
Volgograd State Medical University
Russian Federation
Russian Federation
Yakovlev Anatolii T., DM Sci (habil.), professor, head of Dept of Clinical Laboratory Diagnostics
Volgograd
L. P. Knyshova
Centre for Hygiene and Epidemiology in the Volgograd Region
Russian Federation
Russian Federation
Knyshova Liliya P., PhD Med., doctor of clinical laboratory diagnostics
Volgograd
References
1. Benjamin E. J., Virani S. S., Callaway C. W. Chamberlain A. M. et al. Heart disease and stroke statistics 2018 update: A report from the American Heart Association. P. 137. DOI: 10.1161/cir.0000000000000558.
2. The L. GBD 2017: A fragile world. Lancet. Lond. Engl. 2018, 392, 1683.
3. Information on the socio-economic situation in Russia. Federal State Statistics Service. M., 2019. P. 116–117.
4. Goff D. C., Lloyd-Jones D.M., Bennett G., Coady S., D’Agostino R.B., Gibbons R. et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129: S 49–73. DOI: 10.1161/01.cir.0000437738.63853.7a.
5. Shenderov B. A. Normal microflora and its role in maintaining human health. Russian Journal of Gastroenterology, Hepatology, Colonoproctology. 2008. No. 1. P. 61–65.
6. Tikhonova O. N. Clinical and pathogenetic substantiation of microbiocenosis-sparing therapy for acute intestinal infections in children. IS HE. Tikhonov: dis. … cand. PhD Med: 14.00.09. M., 2008. 138 p.
7. Yan A. W., Fouts D. E., Brandl J., Stärkel P. et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011. Vol. 53. No. 1. P. 96–105.
8. Kashukh E. A. Effect of regulation of metabolic activity of the gut microbiome by antibiotics and probiotics on measures of cardiovascular risk in patients with coronary artery disease. E. A. Kashukh: dis. … PhD Med: 14.01.04. M., 2020. 132 p.
9. Christopher J. Czura, Mauriciorosas-Ballina, Kevin J. Tracey. Psychoneuroimmunology (Fourth Edition). Vol. 1, 2007, P. 85–96. DOI: 10.1016/B 978–012088576–3/50007–1.
10. Koeth R. A., Wang Z., Levison B. S. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19 (5): 576–85. DOI: 10.1038/nm.3145.
11. Tang T. V.H., Chen H-C., Chen C-Y. et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation. 2019. 139. P. 647–659.
12. Lam V., Su J., Koprowski S., Hsu A. et al. Intestinal microbiota determine severity of myocardial infarction in rats. Faseb J. 2012. 26. P. 1727–1735.
13. Fadeeva M. V., Kudryavtseva A. V., Krasnov G. S. and others. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020. V. 30. No. 2. P. 35–44. DOI: 10.22416/1382–4376–2020–30–2–35–44.
14. Yakovlev A. T., Poroisky S. V., Knyshova L. P., Morkovin E. I. Changes in the intestinal microbiota in chronic alcoholism. A. T. Yakovlev, S. V. Poroisky, L. P. Knyshova, E. I. Morkovin. Samara Scientific Bulletin. 2017. V. 6. No. 3 (20). P. 64–67.
15. Order of the Ministry of Health of the Russian Federation No. 231 of 2003.06.09. Industry Standard ‘Patient Management Protocol. Intestinal dysbiosis’ (OST 91500.11.0004–2003).
16. Pluznick J.A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes. 2014; 5 (2): 202–7. DOI: 10.4161/gmic.27492.
Review
For citations:
Bukaevskaya A.Yu., Yakovlev A.T., Knyshova L.P. Role of intestinal microbiocenosis in pathogenesis of acute myocardial infarction. Medical alphabet. 2022;(30):34‑36. (In Russ.) https://doi.org/10.33667/2078-5631-2022-30-34-36
Views:
275
Email this article 